Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,875 | -21,061 | -5,482 | 305 | -10,606 |
| Depreciation Amortization | 8,999 | 66,835 | 50,819 | 33,425 | 16,745 |
| Income taxes - deferred | N/A | N/A | 263 | N/A | N/A |
| Accounts receivable | 11,355 | 9,092 | 9,459 | 5,716 | 4,442 |
| Accounts payable and accrued liabilities | -5,815 | -4,585 | -8,569 | 6,908 | -8,095 |
| Other Working Capital | -1,225 | -5,655 | -24,462 | -3,341 | -20,525 |
| Other Operating Activity | 19,230 | 22,347 | 19,696 | 2,881 | 8,923 |
| Operating Cash Flow | $-29,331 | $66,973 | $41,724 | $45,894 | $-9,116 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 59,533 | N/A | 59,283 | 27,055 | -3,387 |
| PPE Investments | 508,432 | -73,835 | -82,215 | -53,737 | -16,768 |
| Purchase Of Investment | N/A | -134,588 | N/A | N/A | N/A |
| Sale Of Investment | 0 | 291,083 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -10,005 | -10,005 | -10,005 | -10,005 |
| Investing Cash Flow | $567,965 | $72,655 | $-32,937 | $-36,687 | $-30,160 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,118 | 1,884 | N/A | N/A |
| Debt Repayment | N/A | -7,394 | -1,784 | -1,529 | -1,208 |
| Common Stock Issued | 4,965 | 27,273 | 22,107 | 18,720 | 4,019 |
| Other Financing Activity | 21,428 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $26,393 | $21,997 | $22,207 | $17,191 | $2,811 |
| Beginning Cash Position | 340,634 | 179,009 | 179,009 | 179,009 | 179,009 |
| End Cash Position | 905,661 | 340,634 | 210,003 | 205,407 | 142,544 |
| Net Cash Flow | $565,027 | $161,625 | $30,994 | $26,398 | $-36,465 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,331 | 66,973 | 41,724 | 45,894 | -9,116 |
| Capital Expenditure | -1,073 | -94,738 | -82,515 | -53,737 | -16,768 |
| Free Cash Flow | -30,404 | -27,765 | -40,791 | -7,843 | -25,884 |